Edge Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $29.2M | Sell |
908,603
-759,647
| -46% | -$24.4M | 0.22% | 138 |
|
|
2016
Q4 | $60.5M | Buy |
1,668,250
+99,879
| +6% | +$3.62M | 0.47% | 77 |
|
|
2016
Q3 | $72.2M | Buy |
1,568,371
+299,924
| +24% | +$13.8M | 0.6% | 51 |
|
|
2016
Q2 | $63.7M | Buy |
1,268,447
+6,207
| +0.5% | +$312K | 0.57% | 56 |
|
|
2016
Q1 | $67.5M | Sell |
1,262,240
-35,318
| -3% | -$1.89M | 0.65% | 53 |
|
|
2015
Q4 | $85.2M | Buy |
1,297,558
+27,716
| +2% | +$1.82M | 0.83% | 38 |
|
|
2015
Q3 | $71.7M | Sell |
1,269,842
-367,136
| -22% | -$20.7M | 0.72% | 46 |
|
|
2015
Q2 | $96.7M | Sell |
1,636,978
-188,731
| -10% | -$11.2M | 0.88% | 35 |
|
|
2015
Q1 | $114M | Buy |
1,825,709
+11,591
| +0.6% | +$722K | 0.99% | 25 |
|
|
2014
Q4 | $104M | Sell |
1,814,118
-42,090
| -2% | -$2.42M | 1.01% | 27 |
|
|
2014
Q3 | $99.8M | Buy |
1,856,208
+23,600
| +1% | +$1.27M | 1% | 28 |
|
|
2014
Q2 | $96.1M | Sell |
1,832,608
-74,243
| -4% | -$3.89M | 0.96% | 29 |
|
|
2014
Q1 | $101M | Sell |
1,906,851
-317,341
| -14% | -$16.8M | 1.07% | 25 |
|
|
2013
Q4 | $89.1M | Sell |
2,224,192
-1,266,084
| -36% | -$50.7M | 0.97% | 28 |
|
|
2013
Q3 | $135M | Buy |
3,490,276
+1,593,333
| +84% | +$61.4M | 0.82% | 43 |
|
|
2013
Q2 | $74.4M | Buy |
+1,896,943
| New | +$74.4M | 0.93% | 36 |
|